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Background: Different population studies have reported gender difference in carotid intima-media thickness
(CIMT), which is proved to be a risk factor of cardiovascular diseases. However, few longitudinal researches examine
this gender difference in type 2 diabetes mellitus (T2DM) patients. Therefore, we prospectively analyzed CIMT in
T2DM patients over a 4-year follow-up period.
Methods: 355 T2DM patients (mean age 59 years; 54.9% women) were included in the present study. CIMT were
measured using Color Doppler ultrasound. CIMT was measured at baseline (CIMT) in 2006 and at follow-up in 2010.
Biochemical and clinical measurements were collected at baseline.
Results: Mean value of CIMT1 and CIMT2 were 0.740 ± 0.148 mm and 0.842 ± 0.179 mm, respectively. Men had
higher CIMT than women both at baseline and at follow-up (CIMT1: 0.762 ± 0.149 vs 0.723 ± 0.146 mm, P= 0.0149;
CIMT2: 0.880 ± 0.189 vs 0.810 ± 0.164 mm, P= 0.0002). Mean annual progression of CIMT (dCIMT) was
0.025 ± 0.022 mm/year. dCIMT was larger in men than in women (0.030 ± 0.025 vs 0.022 ± 0.019 mm, P= 0.0006). In
multiple regression analyses, age was an independent risk factor of CIMT in both genders, while dCIMT was
associated with age only in men.
Conclusions: Gender difference in CIMT was confirmed in T2DM patients. Moreover, impact of ageing on CIMT
progression only existed in men, which might be the reason that gender difference in CIMT increased with age.
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Patients with type 2 diabetes mellitus (T2DM) have 2–6
fold higher risk of cardiovascular disease (CVD) than
non-diabetics [1], which accounts for nearly 50% dia-
betes-related mortality [2]. Carotid intima-media thick-
ness (CIMT) measured by ultrasound has been proved
to be an independent risk factor of CVD [3,4]. It is suit-
able for large population study, because this measure-
ment is non-invasive, low-cost and convenient.
Moreover, CIMT has been used in clinical trials to
evaluate the efficacy of anti-diabetic, anti-hyperlipidemia
and anti-hypertensive treatments [5-8].* Correspondence: shanghairuijin@126.com
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reproduction in any medium, provided the orCross-sectional population studies have demonstrated
that men usually have higher CIMT than women of
similar age [9-11]. However, gender difference in CIMT
has been seldom studied in longitudinal studies, espe-
cially in T2DM patients [12-17].
Therefore, we prospectively analyzed CIMT in T2DM
patients over a 4-year follow-up period in aim to investi-
gate gender difference in CIMT and to track CIMT
progression.Methods
Subjects
The Ethics Committee of Ruijin Hospital, Shanghai Jiao-
tong University School of Medicine approved the study
protocol. From October 2006 to February 2007, 901
T2DM patients (diagnosed according to the 1999 World
Health Organization criteria [18]) were recruited via thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 B-mode tomographic ultrasound figures at CIMT1 and CIMT2. The distance between two cross marks: carotid intima-media
thickness (CIMT). (A: using Esaote DU3, Italy in 2006; B: using Esaote Mylab90, Italy in 2010).
Table 1 Characteristics of patients at baseline
Characteristics Men Women P
Number 160 195
Age (years) 59.1 ± 9.5 58.5 ± 7.9 0.47
Duration (years) 7.0 ± 5.9 7.8 ± 5.7 0.18
Body mass index (kg/m2) 24.4 ± 2.8 24.3 ± 3.4 0.73
Systolic blood pressure (mmHg) 122.2 ± 10.8 124.6 ± 14.6 0.10
Diastolic blood pressure (mmHg) 78.2 ± 7.4 77.2 ± 8.6 0.25
HbA1c (%) 6.7 ± 1.1 6.7 ± 1.2 0.99
Total cholesterol (mmol/L) 5.0 ± 0.9 5.1 ± 0.8 0.09
Triglycerides (mmol/L) 1.4 ± 1.0 1.5 ± 0.8 0.40
HDL cholesterol (mmol/L) 1.5 ± 0.3 1.5 ± 0.2 0.05
LDL cholesterol (mmol/L) 3.0 ± 0.7 3.1 ± 0.6 0.23
Smoking (%) 17.2 18.5 0.76
Alcohol intake (%) 10.2 7.7 0.44
History of hypertension (%) 51.9 53.8 0.71
History of hyperlipidemia (%) 40.6 43.1 0.64
Anti-diabetic treatment (%) 81.9 83.6 0.67
Anti-hyperlipidemia treatment (%) 13.8 20.0 0.12
Anti-hypertensive treatment (%) 51.3 51.3 0.99
Cardiovascular disease (%) 8.1 13.3 0.13
Microvascular disease (%) 29.4 34.9 0.31
Abbreviations: HDL high density lipoprotein, LDL low density lipoprotein.
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Metabolism at Ruijin Hospital, Shanghai. All study parti-
cipants gave written informed consent. Among them,
501 patients underwent carotid ultrasonographic exam-
ination both at baseline (2006) and at follow-up (2010).
Among them, 68 patients were excluded because of
missing clinical information and/or biochemical indices.
Both female and male patients were divided into three
groups according to their baseline age: ≤55 years, 56–
64 years and ≥65 years (at follow-up: ≤59 years, 60–
68 years and ≥69 years). We excluded 78 patients in
order to make other potential risk factors of CIMT (in-
cluding age, body mass index [BMI], systolic and dia-
stolic blood pressure, serum concentrations of high
density lipoprotein [HDL] and low density lipoprotein
[LDL] cholesterol, total cholesterol, triglycerides, plasma
glycosylated hemoglobin A1c [HbA1c], smoking and
drinking alcohol) comparable between men and women
in each age group. Thus, the present analysis included
355 subjects.
Clinical and biochemical assessments
Blood pressure was measured using a standard mercury
sphygmomanometer in the sitting position after the
patients had rested for at least 10 min. Body mass index
was calculated as weight in kilograms divided by height
in meter squared. A standardized questionnaire was
used to collect information on medical history including
the duration of type 2 diabetes mellitus and lifestyle.
Blood samples were obtained after an overnight fast-
ing. Plasma HbA1c was measured by high-performance
liquid chromatography (BRO-RAD Company, USA).
Serum concentrations of total cholesterol and triglycer-
ides were measured by the enzymatic method, and high
density lipoprotein (HDL) cholesterol was measured
using a specific precipitation method (Beckman LX-20,Brea, CA, USA). Low density lipoprotein (LDL) choles-
terol was calculated using the Friedewald’s formula [19].
Cardiovascular disease was defined as angina, myocar-
dial infarction or revascularization. Microvascular dis-
ease was defined as diabetic retinopathy, nephropathy or
neuropathy.
CIMT measurement
In 2006 and 2010, the same trained sonographers, who
were unaware of the clinical and biochemical
Table 2 Carotid intima-media thickness at baseline and
follow-up
Characteristics Men Women P
CIMT1 (mm) 0.762± 0.149 0.723± 0.146 0.0149
CIMT2 (mm) 0.880± 0.189 0.810± 0.164 0.0002
dCIMT (mm/year) 0.030 ± 0.025 0.022± 0.019 0.0006
Abbreviations: CIMT1 Carotid intima-media thickness at baseline, CIMT2 carotid
intima-media thickness at follow-up, dCIMT progression in carotid intima-media
thickness, it was calculated as (CIMT2-CIMT1)/4 years.
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ments manually using a high-resolution B-mode tomo-
graphic ultrasound system (Esaote DU3 and Mylab90,
Italy) with a linear 7.5-10 MHz transducer (Figure 1).
Precision of the CIMT measurement is 0.01 mm. The
sonographers measured CIMT on the fall wall of the
right and left common carotid arteries, 1.5 cm proximal
to the bifurcation. The transducer was manipulated so
that the lumen diameter was maximized in the longitu-
dinal plane. The first and second lines represent the
lumen–intimal interface and the collage-contained upper
layer of tunic adventitia, respectively [20]. The mean
value of the right and left common carotid IMT was
used for analysis. The baseline and follow-up CIMT
were recorded as CIMT1 and CIMT2, respectively. Pro-
gression of CIMT was calculated as the difference be-
tween CIMT1 and CIMT2 divided by 4 years and
recorded as dCIMT. We performed reproducibility study
in 20 subjects. The coefficient of variations were less
than 5.1%.
Statistical analysis
For database management and statistical analysis, we
used SPSS version 13.0. Variables with a skewed distri-
bution including systolic and diastolic blood pressure,
HbA1c, TG, and HDL cholesterol were normalized by
logarithmic transformation. Comparisons of means and
proportions were performed with analyses of variance
(ANOVA) and Chi-square test, respectively. UnivariateFigure 2 Carotid intima media-thickness at baseline (CIMT1) and follo
(dCIMT) by sex and age groups.correlations were evaluated by Pearson’s and Spearman’s
analyses. We searched for possible covariables of CIMT,
using a stepwise regression procedure with the P-values
for independent variables to enter and to stay in the
model set at 0.05. As covariables, we considered age,
BMI, systolic and diastolic blood pressure, HDL and
LDL cholesterol, total cholesterol, triglycerides, HbA1c,
smoking and alcohol intake.Results
Characteristics of the patients
355 subjects were included in the present study
(Table 1). Clinical and biochemical variables at baseline
were not significantly different between men and
women. During a 4-year follow-up, 39 patients (women
vs men 26 vs 13, P = 0.13) had cardiovascular events and
115 patients (68 vs 47, P = 0.30) developed microvascu-
lar diseases.Carotid intima-media thickness
CIMT
CIMT2 were higher than CIMT1 both in women and in
men (Table 2). At baseline and follow-up, men had lar-
ger CIMT than women. Figure 2 showed CIMT by gen-
der and age groups. Both female and male patients were
divided into three groups according to their baseline
age: ≤55 years (follow-up: ≤59 years) (men 46, women
66), 56–64 years (60–68 years) (men 66, women 87) and
≥65 years (≥69 years) (men 48, women 42). In each age
group, clinical and biochemical measurements did not
have significant differences between women and men.
CIMT1 and CIMT2 increased across the age groups in
both genders (P< 0.001). Men had higher CIMT2 than
women in the group with age ≥69 years at follow-up (P
< 0.05, Figure 2). After adjustment for other covariables,
age was associated with CIMT1 in both genders, while
BMI was associated with CIMT1 in women (Table 3).w-up (CIMT2), and carotid intima-media thickness progression










Age (years) 0.373 <0.001
Body mass index (kg/m2) 0.192 0.008
Men
Age (years) 0.508 <0.001 0.194 0.031
The covariables considered for entry into the multiple regression model were
age, body mass index, systolic and diastolic blood pressure, high density and
low density lipoprotein cholesterol, total cholesterol, triglycerides, smoking
and drinking.
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Compared with men, women had lower dCIMT
(Table 2). In the same age group, dCIMT was higher in
men than in women, but significant difference only
existed in the group with age ≥65 years (P< 0.05,
Figure 2). The association between age and dCIMT was
observed only in men (P= 0.01, Figure 2). After adjust-
ment for other covariables, this association remained
significant (P= 0.031, Table 3).
Discussion
The present study found that T2DM men had higher
CIMT than T2DM women, especially in those with age ≥
69 years. Age was the main risk factors of CIMT in both
genders. However, the impact of ageing on CIMT pro-
gression only existed in male patients.
The gender difference in CIMT in T2DM patients was
in line with other population researches. In a study of
healthy Taiwan population, CIMT was significantly
higher in men than in women (0.558 vs 0.527 mm,
P= 0.012) [21]. Kablak-Ziembicka et al confirmed this
result in subjects without CVD (men vs women 1.05 vs
0.93 mm, P< 0.001) [22]. CIMT in our study was higher
than that in Taiwan healthy population, while was lower
than that in population without CVD [22] or with nor-
mal glucose tolerance [23]. This might be due to the dif-
ferences in age, ethnicity and physical condition of study
populations.
We found that gender difference in CIMT only existed
in the group with age ≥ 69 years. This finding was con-
sistent with the Tromsø study [24], which found that
gender difference in CIMT was not significant in young
population and gradually increased with age [24]. Dalla
Pozza et al reported that there CIMT was not different
between male and female children with type 1 diabetes
mellitus [25]. However, contrary results were found in
subjects without CVD risk factors studied by Sinning et
al [26]. In their study, gender difference in CIMT only
exists in young population (mean age: 35 years) but notin elderly population (age range: 55–72 years) [26]. The
possible reason might be that the estrogen, which sup-
pressed the progression of arteriosclerosis, decreased in
postmenopausal women. Thus, gender difference in
CIMT was weakened in elderly population as observed
by Sinning et al. However, our subjects were patients
with diabetics, which is an important and independent
risk factor of CVD. Hayashi et al reported gender differ-
ence in CVD risk factors [27], which may cause gender
difference in CIMT. Moreover, men are more susceptible
to CVD risk factor than women [28-30]. Therefore, gen-
der difference in CIMT was significant in our study due
to diabetic status.
Another main finding of our study was that CIMT
progression was faster in men than women, which was
in keeping with other studies [24,31]. Stensland-Bugge et
al reported that the average progression per year of
CIMT was greater in men than in women (0.010 mm
versus 0.009 mm, P< 0.01) [24]. In the present study,
these value were 0.030 mm for men and 0.022 mm for
women (P< 0.01). The progression of CIMT in our
study was higher than those reported from healthy
population (0.007 mm/year in Germen, 0.008 mm/year
in Japanese) [32,33] and similar to those reported from
subjects with impaired glucose tolerance [34] and
T2DM [35]. In the current study, after adjustment for
other covariables, age was an independent risk factors of
CIMT progression only in men. This might be the rea-
son that men had higher CIMT than women and this
gender difference was more significant in patients with
old age and more significant after a 4-year follow-up.
The present study must be interpreted within the con-
text of its limitations. First, we did not find gender dif-
ference in the incidence of cardiovascular diseases or
microvascular diseases after a 4-year follow-up, although
men had higher CIMT than women at baseline. This
might be due to the small sample size and the relatively
short follow-up period. Second, we did not categorize
anti-diabetic treatment, which might have effect on the
results.Conclusion
Our study showed that age was the most important and
independent risk factor of CIMT in diabetics. However,
impact of ageing on CIMT progression only existed in
T2DM men, which might lead to the phenomenon that
gender difference in CIMT increased with age.
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